Cal-Maine Foods Inc
CALM- Exchange
- Nasdaq
- Industry
- Agricultural Prod-Livestock & Animal Specialties
- SEC CIK
- 0000016160
No open-market purchases or sales by Cal-Maine Foods Inc insiders were filed in the last 90 days; 461 institutions reported holding it in 13F filings for Q2 2026, worth $3.59B in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 8, 2026, 11:03 AM ET
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Period end | May 30, 2026 | May 31, 2025 | Jun 1, 2024 | Jun 3, 2023 | May 28, 2022 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jul 22, 2026 | Jul 22, 2025 | Jul 23, 2024 | Jul 25, 2023 | Jul 19, 2022 |
| Revenue | $2.91B | $4.26B | $2.33B | $3.15B | $1.78B |
| Cost of revenue | $2.24B | $2.41B | $1.78B | $1.95B | $1.44B |
| Gross profit | $672.0M | $1.85B | $541.6M | $1.20B | $337.1M |
| Selling, general and administrative | $329.3M | $314.4M | $252.6M | $232.2M | $198.6M |
| Operating income | $350.2M | $1.54B | $312.5M | $967.7M | $143.5M |
| Interest expense | – | – | $549.0K | $583.0K | $403.0K |
| Income tax | $92.9M | $384.9M | $83.7M | $241.8M | $33.6M |
| Net income | $316.7M | $1.22B | $277.9M | $758.0M | $132.7M |
| EPS, basic | $6.65 | $25.04 | $5.70 | $15.58 | $2.73 |
| EPS, diluted | $6.63 | $24.95 | $5.69 | $15.52 | $2.72 |
| Weighted shares, basic | 47.6M | 48.7M | 48.7M | 48.6M | 48.6M |
| Weighted shares, diluted | 47.8M | 48.9M | 48.9M | 48.8M | 48.7M |
| Margins and growth | |||||
| Gross margin | 23.1% | 43.4% | 23.3% | 38.0% | 19.0% |
| Operating margin | 12.0% | 36.1% | 13.4% | 30.8% | 8.1% |
| Net margin | 10.9% | 28.6% | 11.9% | 24.1% | 7.5% |
| Revenue growth, year over year | −31.7% | +83.2% | −26.1% | +77.0% | +31.7% |
| Net income growth, year over year | −74.0% | +339.0% | −63.3% | +471.4% | +6,339.3% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Period end | May 30, 2026 | May 31, 2025 | Jun 1, 2024 | Jun 3, 2023 | May 28, 2022 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jul 22, 2026 | Jul 22, 2025 | Jul 23, 2024 | Jul 25, 2023 | Jul 19, 2022 |
| Cash and equivalents | $107.2M | $499.4M | $237.9M | $292.8M | $59.1M |
| Accounts receivable | $136.2M | $244.1M | $138.6M | $111.0M | $169.1M |
| Inventory | $375.3M | $295.7M | $261.8M | $284.4M | $263.3M |
| Total current assets | $1.58B | $1.97B | $1.24B | $1.12B | $661.5M |
| Property, plant and equipment | $1.32B | $1.03B | $857.2M | $744.5M | $677.8M |
| Goodwill | $97.1M | $46.8M | $45.8M | $44.0M | $44.0M |
| Intangible assets | $73.1M | $15.2M | $16.0M | $15.9M | $18.1M |
| Total assets | $3.11B | $3.08B | $2.18B | $1.95B | $1.43B |
| Accounts payable | $96.1M | $101.0M | $75.9M | $82.6M | $82.0M |
| Total current liabilities | $205.5M | $308.4M | $227.7M | $182.7M | $184.7M |
| Total liabilities | $467.0M | $518.6M | $387.7M | $344.9M | $323.1M |
| Shareholders' equity | $2.64B | $2.57B | $1.80B | $1.61B | $1.10B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Period end | May 30, 2026 | May 31, 2025 | Jun 1, 2024 | Jun 3, 2023 | May 28, 2022 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jul 22, 2026 | Jul 22, 2025 | Jul 23, 2024 | Jul 25, 2023 | Jul 19, 2022 |
| Operating cash flow | $479.8M | $1.22B | $451.4M | $863.0M | $126.2M |
| Capital expenditures | $151.2M | $161.3M | $147.1M | $136.6M | $72.4M |
| Free cash flow | $328.5M | $1.06B | $304.3M | $726.4M | $53.8M |
| Depreciation and amortization | $124.3M | $94.0M | $80.2M | $72.2M | $68.4M |
| Stock-based compensation | $5.76M | $4.53M | $4.36M | $4.21M | $4.06M |
| Dividends paid | $231.6M | $330.3M | $91.9M | $252.3M | $6.12M |
| Investing cash flow | -$503.9M | -$575.5M | -$412.6M | -$375.1M | -$117.0M |
| Financing cash flow | -$362.7M | -$386.7M | -$93.8M | -$254.2M | -$7.46M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 0.2% | 0.1% | 0.2% | 0.1% | 0.2% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.